EPIDEMIOLOGY, CLINICAL CHARACTERISTICS, PREVENTION AND CONTROL OF CORONAVIRUS - A REVIEW
DOI:
https://doi.org/10.61841/9pw2vm38Keywords:
Awareness, COVID -19, Human transmission, Symptoms, Treatment, controlAbstract
The world is in a big lockdown due to the coronavirus. It is caused by a novel virus , a modification of SARS-CoV-2, and is spread through human-to-human transmission, and as the days pass by, the death rate is increasing rapidly as people are not following the prevention protocol properly, and some are still not aware of the serious effects and preventive measures to be taken. It appeared just one month before the spring festival of China, and the massive population flow has brought great challenges for control and prevention of the disease. No specific therapeutic drug has been found for this disease. Hence, health education on knowledge for controlling the disease is important. So, this review focuses on decreasing the mortality rate and thereby helping people return to their normal life. The review was made by collecting information based on the keywords and important points in relation to the topic through search engines like PubMed and Google Scholar.The present study summarizes and gives an overview of COVID-19 that provides an insight to the people on this deadly disease and hence helps the people to stay safe.
Downloads
References
[1] Deng S-Q, Peng H-J. Characteristics of and Public Health Responses to the Coronavirus Disease 2019
Outbreak in China. J Clin Med Res; 9. Epub ahead of print 20 February 2020. DOI: 10.3390/jcm9020575.
[2] Samuel AR, Devi MG. Geographical distribution and occurrence of endemic goiter. Research Journal of
Pharmacy and Technology 2015; 8: 973.
[3] The Public’s Awareness Of and Concerns About Coronavirus. KFF, https://www.kff.org/coronaviruscovid-19/issue-brief/the-publics-awareness-of-and-concerns-about-coronavirus/ (2020, accessed 3 June
2020).
[4] Baheerati MM, Gayatri Devi R. Obesity in relation to infertility. Research Journal of Pharmacy and
Technology 2018; 11: 3183.
[5] Nooh HZ, Alshammary RH, Alenezy JM, et al. Public awareness of coronavirus in Al-Jouf region, Saudi
Arabia. Z Gesundh Wiss 2020; 1–8.
[6] Fathima F, Preetha P. EVALUATION OF THYROID FUNCTION TEST IN OBESE PATIENTS. Asian
Journal of Pharmaceutical and Clinical Research 2016; 9: 353.
[7] Khot WY, Nadkar MY. The 2019 Novel Coronavirus Outbreak - A Global Threat. J Assoc Physicians
India 2020; 68: 67–71.
[8] Rj I, R GD. Role of environmental factors on sleep patterns of different age groups. Asian Journal of
Pharmaceutical and Clinical Research 2016; 9: 124.
[9] Zu ZY, Jiang MD, Xu PP, et al. Coronavirus Disease 2019 (COVID-19): A Perspective from China.
Radiology 2020; 200490.
[10] Harsha L, Priya J, Shah KK, et al. Systemic Approach to Management of Neonatal Jaundice and
Prevention of Kernicterus. Research Journal of Pharmacy and Technology 2015; 8: 1087.
[11] Weiss SR, Navas-Martin S. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory
syndrome coronavirus. Microbiol Mol Biol Rev 2005; 69: 635–664.
[12] Dave PH, Preetha. Pathogenesis and Novel Drug for Treatment of Asthma-A Review. Research Journal
of Pharmacy and Technology 2016; 9: 1519.
[13] Chan JF-W, Yuan S, Kok K-H, et al. A familial cluster of pneumonia associated with the 2019 novel
Coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020; 395: 514–
523.
[14] Abigail, Priya J., et al. Evaluation of Muscular Endurance among Dentists. Indian Journal of Public
Health Research & Development 2019; 10: 258.
[15] Lipsitch M, Swerdlow DL, Finelli L. Defining the Epidemiology of Covid-19 - Studies Needed. N Engl J
Med 2020; 382: 1194–1196.
[16] Shruthi M, Preetha S. Effect of Simple Tongue Exercises in Habitual Snorers. Research Journal of
Pharmacy and Technology 2018; 11: 3614.
[17] Ge H, Wang X, Yuan X, et al. The epidemiology and clinical information about COVID-19. Eur J Clin
Microbiol Infect Dis 2020; 39: 1011–1019.
[18] Choudhari S, Jothipriya MA. Non-alcoholic fatty liver disease. Research Journal of Pharmacy and
Technology 2016; 9: 1782.
[19] Siordia JA Jr. Epidemiology and clinical features of COVID-19: A review of current literature. J Clin Virol 2020; 127: 104357.
[20] Iyer PK, Gayatri Devi R, Jothi Priya A. A Survey Study on Causes, Treatment and Prevention of
Onychocryptosis. Indian Journal of Public Health Research & Development 2019; 10: 807.
[21] Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N
Engl J Med 2020; 382: 727–733.
[22] R GD, Sethu G. EVALUATION OF ADENOIDS BY ORONASAL AND NASAL SPIROMETRY. Asian
Journal of Pharmaceutical and Clinical Research 2018; 11: 272.
[23] Li W, Sui J, Huang I-C, et al. The S proteins of human coronavirus NL63 and severe acute respiratory
Syndrome coronavirus binds overlapping regions of ACE2. Virology 2007; 367: 367–374.
[24] Swathy S, Gowri Sethu V. Acupuncture and lower back pain. Research Journal of Pharmacy and
Technology 2015; 8: 991.
[25] Hulswit RJG, Lang Y, Bakkers MJG, et al. Human coronaviruses OC43 and HKU1 bind to 9-O-acetylated
sialic acids via a conserved receptor-binding site in spike protein domain A. Proceedings of the National
Academy of Sciences 2019; 116: 2681–2690.
[26] Renuka S, Sethu G. Regeneration after Myocardial Infarction. Research Journal of Pharmacy and
Technology 2015; 8: 738.
[27] Xu X, Chen P, Wang J, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and
modeling of its spike protein for risk of human transmission. Science China Life Sciences 2020; 63: 457–
460.
[28] Timothy CN, Gayatri Devi R, Jothi Priya A. Evaluation of Peak Expiratory Flow Rate (PEFR) in Pet
Owners. Indian Journal of Public Health Research & Development 2019; 10: 803.
[29] The General Office of National Health Commission. Diagnosis and Treatment Protocol for Novel
Coronavirus Pneumonia (Trial Version 6, Revised). Chinese medical journal,
http://www.kankyokansen.org/uploads/uploads/files/jsipc/protocol_V6.pdf (2020).
[30] David, Priya AJ, Devi G. Physical Fitness among the Dental Physician, Dental Undergraduates and
Postgraduate Students. Indian Journal of Public Health Research & Development 2019; 10: 223–226.
[31] Mclntosh K. Coronavirus disease 2019 (COVID-19): Epidemiology, virology, and prevention. Up-to-date,
https://www.uptodate.com/contents/coronavirus-disease-2019-covid-19-epidemiology-virology-andprevention (2020, accessed 3 June 2020).
[32] Deville JG. Coronavirus disease 2019 (COVID-19): Considerations in children. In: Edwards MS, Torchia
MM (eds) UpToDate. Waltham, MA: UpToDate, https://www.uptodate.com/contents/coronavirusdisease-2019-covid-19-considerations-in-children (2020).
[33] Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in
Wuhan, China. Lancet 2020; 395: 497–506.
[34] Ahmad S. A Review of COVID-19 (Coronavirus Disease-2019) Diagnosis, Treatments, and Prevention.
Eurasian Journal of Medicine and Oncology. Epub ahead of print 2020. DOI: 10.14744/ejmo.2020.90853.
[35] Cascella M, Rajnik M, Cuomo A, et al. Features, Evaluation, and Treatment of Coronavirus (COVID-19). In:
StatPearls. Treasure Island (FL): StatPearls Publishing, https://www.ncbi.nlm.nih.gov/pubmed/32150360
(2020).
[36] Govt C. New Coronavirus Infection Pneumonia Prevention and Control Plan (Second Edition). 19.
National Health Commission of the People’s Republic of China. Technical Guide for Prevention and
Control of New Coronavirus Infection in Medical Institutions (Second Edition) (2020-01-22)., http://www.nhc.gov.cn/jkj/s3577/202001/c67cfe29ecf1470e8c7fc47d3b751e88.shtml (accessed on 19
February 2020). (2020, accessed 3 June 2020).
[37] Adhikari SP, Meng S, Wu Y-J, et al. Epidemiology, causes, clinical manifestation and diagnosis,
prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping
review. Infect Dis Poverty 2020; 9: 29.
[38] Guan W-J, Chen R-C, Zhong N-S. Strategies for the prevention and management of coronavirus disease
2019. Eur Respir J; 55. Epub ahead of print April 2020. DOI:10.1183/13993003.00597-2020.
[39] Farhat Yaasmeen Sadique Basha, Rajeshkumar S, Lakshmi T, Anti-inflammatory activity of Myristica
fragrance extract. Int. J. Res. Pharm. Sci., 2019; 10(4), 3118-3120 DOI: https://doi.org/10.26452/ijrps.v10i4.1607
Downloads
Published
Issue
Section
License
Copyright (c) 2020 AUTHOR
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
